Real-time enrollment status for this juvenile myelomonocytic leukemia clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 11:16 PM UTC
| NCT Number | NCT03326921 |
| Recruiting Status | Recruiting |
| Condition | Juvenile Myelomonocytic Leukemia |
| Phase | PHASE1 |
| Target Enrollment | 24 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Fred Hutchinson Cancer Center |
| Last Updated on CT.gov | May 18, 2026 (May 18, 2026) |
As of July 17, 2026: Clinical trial NCT03326921 is currently recruiting participants. This phase1 study for juvenile myelomonocytic leukemia is actively seeking new participants at 1 location across the United States. The study is sponsored by Fred Hutchinson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03326921 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03326921 was last updated May 18, 2026 (May 18, 2026). HelloStudys verifies this status automatically.